| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 341 |
| 1 | ADALIMUMAB | 315 |
| 2 | METHOTREXATE SODIUM | 305 |
| 3 | METHOTREXATE | 263 |
| 4 | PREDNISONE | 227 |
| 5 | TOCILIZUMAB | 207 |
| 6 | ALBUTEROL SULFATE | 203 |
| 7 | INFLIXIMAB | 200 |
| 8 | ABATACEPT | 197 |
| 9 | RITUXIMAB | 197 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CODEINE SULFATE | 29 | 0.0088 |
| 1 | ACLIDINIUM BROMIDE | 46 | 0.0072 |
| 2 | MEPERIDINE HYDROCHLORIDE | 49 | 0.0052 |
| 3 | ERGOCALCIFEROL | 113 | 0.0038 |
| 4 | LEVALBUTEROL TARTRATE | 13 | 0.0035 |
| 5 | THEOPHYLLINE ANHYDROUS | 38 | 0.0030 |
| 6 | CLINDAMYCIN PHOSPHATE | 16 | 0.0029 |
| 7 | MOXIFLOXACIN HYDROCHLORIDE | 53 | 0.0026 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 19 | 0.0023 |
| 9 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 10 | 0.0022 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 485 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 405 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 327 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 263 |
| 4 | Benzodiazepine [EPC] | 209 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 209 |
| 6 | Interleukin-6 Receptor Antagonist [EPC] | 208 |
| 7 | Selective T Cell Costimulation Modulator [EPC] | 197 |
| 8 | Proton Pump Inhibitor [EPC] | 192 |
| 9 | Antirheumatic Agent [EPC] | 162 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 26 | 0.0378 |
| 1 | Provitamin D2 Compound [EPC] | 113 | 0.0038 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 6 | 0.0029 |
| 3 | Human Immunoglobulin G [EPC] | 34 | 0.0016 |
| 4 | Antirheumatic Agent [EPC] | 162 | 0.0015 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 208 | 0.0015 |
| 6 | Selective T Cell Costimulation Modulator [EPC] | 197 | 0.0014 |
| 7 | Calcitonin [EPC] | 4 | 0.0013 |
| 8 | CD38-directed Cytolytic Antibody [EPC] | 6 | 0.0010 |
| 9 | Human alpha-1 Proteinase Inhibitor [EPC] | 4 | 0.0009 |